Morusin inhibits human cervical cancer stem cell growth and migration through attenuation of NF-κB activity and apoptosis induction

Molecular and Cellular Biochemistry

Volumn 379, Issue 1-2, 2013, Pages 7-18

  Wang, Li ^a   Guo, Huijie ^a   Yang, Liuqi ^a   Dong, Lihua ^a   Lin, Caiyu ^a   Zhang, Jie ^a   Lin, Ping ^a   Wang, Xiujie ^a  

^a SICHUAN UNIVERSITY   (China)

Author keywords

Apoptosis; Cancer stem cells; Cancer stem markers; Cervical cancer; Growth inhibition; Morusin

Indexed keywords

4',6 DIAMIDINO 2 PHENYLINDOLE; ANTINEOPLASTIC AGENT; CASPASE 3; FLAVONOID; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; MORUSIN; OCTAMER TRANSCRIPTION FACTOR 4; PROTEIN BAX; PROTEIN BCL 2; SYNAPTOTAGMIN I; TOLONIUM CHLORIDE; TRANSCRIPTION FACTOR SOX2; UNCLASSIFIED DRUG;

ANTINEOPLASTIC ACTIVITY; APOPTOSIS; ARTICLE; CANCER INHIBITION; CANCER STEM CELL; CELL PROLIFERATION; DNA FRAGMENTATION; EPITHELIAL MESENCHYMAL TRANSITION; FEMALE; HUMAN; HUMAN CELL; IMMUNOFLUORESCENCE; MIGRATION INHIBITION; PROTEIN EXPRESSION; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; STAINING; UTERINE CERVIX CANCER; WESTERN BLOTTING;

ANTINEOPLASTIC AGENTS; APOPTOSIS; APOPTOSIS REGULATORY PROTEINS; CELL MOVEMENT; CELL PROLIFERATION; CELL SHAPE; DNA FRAGMENTATION; DRUG SCREENING ASSAYS, ANTITUMOR; EPITHELIAL-MESENCHYMAL TRANSITION; FEMALE; FLAVONOIDS; GENE EXPRESSION; HELA CELLS; HUMANS; NEOPLASTIC STEM CELLS; OCTAMER TRANSCRIPTION FACTOR-3; SOXB1 TRANSCRIPTION FACTORS; SPHEROIDS, CELLULAR; TRANSCRIPTION FACTOR RELA; UP-REGULATION; UTERINE CERVICAL NEOPLASMS;

EID: 84878433037     PISSN: 03008177     EISSN: 15734919     Source Type: Journal    
DOI: 10.1007/s11010-013-1621-y     Document Type: Article

References (41)

1. Jemal A, Bray F, Center MM, Ferlay J, Ward E, Forman D (2011) Global cancer statistics. CA Cancer J Clin 61:69-90
2. Lea JS, Lin KY (2012) Cervical cancer. Obstet Gynecol Clin North Am 39:233-253
3. Green JA, Kirwan JM, Tierney JF, Symonds P, Fresco L, Collingwood M, Williams CJ (2001) Survival and recurrence after concomitant chemo-therapy and radiotherapy for cancer of the uterine cervix: a systematic review and meta-analysis. Lancet 358:781-786
4. Pectasides D, Kamposioras K, Papaxoinis G, Pectasides E (2008) Chemotherapy for recurrent cervical cancer. Cancer Treat Rev 34:603-613
5. Ichim CV, Wells RA (2006) First among equals: the cancer cell hierarchy. Leuk Lymphoma 47:2017-2027
6. Mao XG, Guo G, Wang P, Zhang X, Xue XY, Zhang W, Fei Z, Jiang XF, Yan M (2010) Maintenance of critical properties of brain tumor stem-like cells after cryopreservation. Cell Mol Neurobiol 30:775-786
7. Iqbal J, Chong PY, Tan PH (2013) Breast cancer stem cells: an update. J Clin Pathol. doi: 10.1136/jclinpath-2012-201304
8. Su YJ, Lai HM, Chang YW, Chen GY, Lee JL (2011) Direct reprogramming of stem cell properties in colon cancer cells by CD44. EMBO J 30:3186-3199
9. Zhang LL, Jiao M, Li L, Wu DP, Wu KJ, Li X, Zhu GD, Dang Q, Wang XY, Hsieh JT, He DL (2012) Tumorspheres derived from prostate cancer cells possess chemoresistant and cancer stem cell properties. J Cancer Res Clin Oncol 138:675-686
10. López J, Poitevin A, Mendoza-Martínez V, Pérez-Plasencia C, García-Carrancá A (2012) Cancer-initiating cells derived from established cervical cell lines exhibit stem-cell markers and increased radioresistance. BMC Cancer 12:48. doi: 10.1186/1471-2407-12-48
11. Xu W, Lin H, Zhang Y, Chen X, Hua B, Hou W, Qi X, Pei Y, Zhu X, Zhao Z, Yang L (2011) Compound Kushen Injection suppresses human breast cancer stem-like cells by down-regulating the canonical Wnt/β-catenin pathway. J Exp Clin Cancer Res 30:103
12. Ko HH, Yu SM, Ko FN, Teng CM, Lin CN (1997) Bioactive constituents of Morus australis and Broussonetia papyrifera. J Nat Prod 60:1008-1011
13. Ko HH, Wang JJ, Lin HC, Wang JP, Lin CN (1999) Chemistry and biological activities of constituents from Morus australis. Biochim Biophys Acta 1428:293-299
14. Sohn HY, Son KH, Kwon CS, Kwon GS, Kang SS (2004) Antimicrobial and cytotoxic activity of 18 prenylated flavonoids isolated from medicinal plants: Morus alba L., Morus mongolica Schneider, Broussnetia papyrifera (L.) Vent, Sophora flavescens Ait and Echinosophora koreensis Nakai. Phytomedicine 11:666-672
15. Lee JC, Won SJ, Chao CL, Wu FL, Liu HS, Ling P, Lin CN, Su CL (2008) Morusin induces apoptosis and suppresses NF-κB activity in human colorectal cancer HT-29 cells. Biochem Biophys Res Commun 372:236-242
16. Dat NT, Binh PT, le Quynh TP, Van Minh C, Huong HT, Lee JJ (2010) Cytotoxic prenylated flavonoids from Morus alba. Fitoterapia 81:1224-1227
17. Kuo SH, Chou CH, Cheng AL, Wang CW, Chen YH, Chen RJ (2012) Expression of BCL10 in cervical cancer has a role in the regulation of cell growth through the activation of NF-κB-dependent cyclin D1 signaling. Gynecol Oncol 126:245-251
18. Hirsch HA, Iliopoulos D, Struhl K (2013) Metformin inhibits the inflammatory response associated with cellular transformation and cancer stem cell growth. Proc Natl Acad Sci U S A 110:972-977
19. Gu W, Yeo E, McMillan N, Yu C (2011) Silencing oncogene expression in cervical cancer stem-like cells inhibits their cell growth and self-renewal ability. Cancer Gene Ther 18:897-905
20. Chen SF, Chang YC, Nieh S, Yang CY, Lin YS (2012) Nonadhesive culture system as a model of rapid sphere formation with cancer stem cell properties. PLoS ONE 7:e31864
21. Ponti D, Costa A, Zaffaroni N, Pratesi G, Petrangolini G, Coradini D, Pilotti S, Pierotti MA, Daidone MG (2005) Isolation and in vitro propagation of tumorigenic breast cancer cells with stem/progenitor cell properties. Cancer Res 65:5506-5511
22. Cioce M, Gherardi S, Viglietto G, Strano S, Blandino G, Muti P, Ciliberto G (2010) Mammosphere-forming cells from breast cancer cell lines as a tool for the identification of CSC-like- and early progenitor-targeting drugs. Cell Cycle 9(14):2878-2887
23. van Meerloo J, Kaspers GJ, Cloos J (2011) Cell sensitivity assays: the MTT assay. Methods Mol Biol 731:237-245
24. Kim MJ, Kim YJ, Park HJ, Chung JH, Leem KH, Kim HK (2006) Apoptotic effect of red wine polyphenols on human colon cancer SNU-C4 cells. Food Chem Toxicol 44:898-902
25. Li H, Wang P, Liu Q, Cheng X, Zhou Y, Xiao Y (2012) Cell cycle arrest and cell apoptosis induced by Equisetum hyemale extract in murine leukemia L1210 cells. J Ethnopharmacol 144:322-327
26. Herrmann M, Lorenz HM, Voll R, Grünke M, Woith W, Kalden JR (1994) A rapid and simple method for the isolation of apoptotic DNA fragments. Nucleic Acids Res 22:5506-5507
27. Gilbert CA, Ross AH (2009) Cancer stem cells: cell culture, markers, and targets for new therapies. J Cell Biochem 1:1031-1038
28. Hu Y, Fu L (2012) Targeting cancer stem cells: a new therapy to cure cancer patients. Am J Cancer Res 2:340-356
29. Clarke MF, Dick JE, Dirks PB, Eaves CJ, Jamieson CH (2006) Cancer stem cells -perspectives on current status and future directions: AACR Workshop on cancer stem cells. Cancer Res 66:9339-9344
30. Kim RK, Kim MJ, Yoon CH, Lim EJ, Yoo KC, Lee GH, Kim YH, Kim H, Jin YB, Lee YJ, Cho CG, Oh YS, Gye MC, Suh Y, Lee SJ (2012) A new 2-pyrone derivative, 5-bromo-3-(3-hydroxyprop-1-ynyl)-2H-pyran-2-one, suppresses stemness in glioma stem-like cells. Mol Pharmacol 82:400-407
31. Cheng W, Liu T, Wan X, Gao Y, Wang H (2012) MicroRNA-199a targets CD44 to suppress the tumorigenicity and multidrug resistance of ovarian cancer-initiating cells. FEBS J 279:2047-2059
32. van de Stolpe A (2013) On the origin and destination of cancer stem cells: a conceptual evaluation. Am J Cancer Res 3:107-116
33. Chen SF, Chang YC, Nieh S, Liu CL, Yang CY, Lin YS (2012) Nonadhesive culture system as a model of rapid sphere formation with cancer stem cell properties. PLoS ONE 7:e31864
34. Mather JP (2012) In vitro models. Stem Cells 30:95-99
35. Tirino V, Desiderio V, Paino F, Papaccio G, De Rosa M (2012) Methods for cancer stem cell detection and isolation. Methods Mol Biol 879:513-529
36. Li JL, Zhou BH (2011) Activation of β-catenin and Akt pathways by twist are critical for the maintenance of EMT associated cancer stem cell-like characters. BMC Cancer 11:49
37. Gilbert CA, Ross AH (2009) Cancer stem cells: cell culture, markers, and targets for new therapies. J Cell Biochem 1:1031-1038
38. Chinn SB, Darr OA, Peters RD, Prince ME (2012) The role of head and neck squamous cell carcinoma cancer stem cells in tumorigenesis, metastasis, and treatment failure. Front Endocrinol (Lausanne) 3:90
39. Zhang SL, Wang YS, Zhou T, Yu XW, Wei ZT, Li YL (2012) Isolation and characterization of cancer stem cells from cervical cancer HeLa cells. Cytotechnology 64:477-484
40. Karin M, Cao Y, Greten FR, Li ZW (2002) NF-kappaB in cancer: from innocent bystander to major culprit. Nat Rev Cancer 2:301-310
41. Lin MT, Chang CC, Chen ST, Chang HL, Su JL, Chau YP, Kuo ML (2004) Cyr61 expression confers resistance to apoptosis in breast cancer MCF-7 cells by a mechanism of NF-kappaB-dependent XIAP up-regulation. J Biol Chem 279:24015-24023